Skip to main content

← All opportunities

VETERANS AFFAIRS, DEPARTMENT OF › 245-NETWORK CONTRACT OFFICE 5 (36C245)

6550--FLOW CYTOMETERY REAGENTS AND SUPPLIES (VA-27-00016081) |

Key facts

Response deadline
Nov 27, 2026
12:00 PM UTC-05:00
Set-aside
Not stated
Notice type
Combined synopsis/solicitation
Posted on SAM.gov
Nov 17, 2026
Archives Jan 26, 2027

Description

Show the full description
Effective Date: 01/15/2026 Revision: 03 Description This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 This solicitation is unrestricted, Full and Open competition. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 1250 employees. The FSC/PSC is 6550. The Network Contracting Office 5 is seeking to purchase BD FACSLyric Flow Cytometry Reagents/Supplies for the Baltimore VAMC located at 10 N Greene Street, Baltimore, MD 21201. All interested companies shall provide quotations for the following: See Attachment labeled Line Item Template Note: All quantities are estimates Statement of Work BD FACSLyric Flow Cytometry Reagents/Supplies Introduction: Technology:End of the preview. Use “Show the full description” above to read all of it.
Effective Date: 01/15/2026 Revision: 03 Description This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format Revolutionary FAR Overhaul (RFO) in Federal Acquisition Regulation (FAR) subpart 12.202, Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 This solicitation is unrestricted, Full and Open competition. The associated North American Industrial Classification System (NAICS) code for this procurement is 325413 with a small business size standard of 1250 employees. The FSC/PSC is 6550. The Network Contracting Office 5 is seeking to purchase BD FACSLyric Flow Cytometry Reagents/Supplies for the Baltimore VAMC located at 10 N Greene Street, Baltimore, MD 21201. All interested companies shall provide quotations for the following: See Attachment labeled Line Item Template Note: All quantities are estimates Statement of Work BD FACSLyric Flow Cytometry Reagents/Supplies Introduction: Technology: Flow cytometry is a technology that simultaneously measures and then analyzes multiple physical characteristics of single particles, usually cells, as they flow in a fluid stream through a beam of light. The parameters measured include the particle size, granularity or internal complexity, and fluorescence intensity. An optical-to-electronic coupling system determines these characteristics by recording how the cell or particle scatters incident laser light and emits fluorescence. These scatter and fluorescence signals, detected by the instrument, provide information about the cell s size, internal complexity, and relative fluorescence intensity. BD Multisets reagents employ fluorescence triggering, allowing direct fluorescence gating of the lymphocyte population to reduce contamination of lyse-resistant or nucleated red blood cells in the gate. To prepare for flow analysis, a patient s whole blood is added to the reagent, and the fluorochrome-labeled antibodies in the reagent bind specifically to the leucocyte s surface antigens. During acquisition, the stained cells travel past the laser beam and scatter the laser light. The staining pattern of each population, combined with forward-scattered light (FSC) and side-scattered light (SSC) data, can be used to identify which cell populations are present in the patient sample. Photodetectors (Photo iodide & Photomultiplier tubes/PMT) convert the light signals to electronic signals, which are then converted into digital channel numbers for display on a data plot. Scope of work: General: The offeror shall provide to the Veterans Affairs Medical Health Care System at Baltimore VAMC all reagents and supplies for flow cytometry testing in the Hematology section of Pathology and Laboratory Medicine Service. The reagents/supplies will be used for CD4/CD8 count testing and the phenotyping of white blood cells in the leukemia and lymphoma assay using the FACSLyric. QC material and calibration material are used for the detection of voltages and spectral overlap to monitor optimal cytometer settings, checks, and track the daily performance. Term of Agreement: The contract term is for 1 year. Performance Period: 12/03/2026 to 12/02/2027 Reagents: Monoclonal Antibodies for Leukemia and lymphoma diagnostic. The quantity of reagents in this list was based on the data collected from the volume of patients received in 2024 and 2025. The leukemia population was around 300 patients, and the CD4/CD8 T-cell helper testing request was around 3000 patients Place of Performance/Place of Delivery Address: 10 N Greene Street, Baltimore, MD 21201. Country: UNITED STATES The full text of FAR provisions or clauses may be accessed electronically at https://www.acquisition.gov/browse/index/far. https://www.va.gov/oal/library/vaar/ The following solicitation provisions and clause apply to this acquisition: FAR 52.212-1, Instructions to Offerors Commercial Products and Commercial Services Solicitation Provisions (Incorporated by Reference) Provision Title Date FAR 52.204-7 System for Award Management Jan 2025 FAR 52.204-16 Commercial and Government Entity Code Reporting Aug 2020 FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment Nov 2021 FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation Jan 2025 FAR 52.212-1 Instructions to Offerors-Commercial Products and Commercial Services Sep 2023 FAR 52.212-2 Evaluation-Commercial Products and Commercial Services Nov 2021 FAR 52.212-3 Offeror Representations and Certifications-Commercial Products and Commercial Services Jan 2025 FAR 52.225-2 Buy American Certificate Feb 2021 VAAR 852.211-73 Brand Name or Equal Feb 2023 Complete Attachment Line Item Template columns K, L N, O, BZ, CF and CH. Do not alter the template beyond those columns. Provide documentation that firm is either the manufacturer or an authorized distributor. All products must be able to work in the Becton Dickinson FACSLyric Flow Cytometry analyzer. All quotes shall be sent to [email protected]. FAR 52.212-2 Evaluation-Commercial Products and Commercial Services: In accordance with RFO FAR 12.201-1 and FAR 12.201-2 when appropriate, the contracting officer may (1) Insert the provision at 52.212-2, Evaluation-Commercial Products and Commercial Services, in solicitations for commercial products or commercial services. The following are the decision factors: Evaluation Criteria: FACTOR (1) Past Performance Acceptable - The company s performance was satisfactory, and you would consider doing business with them again. There were minor performance problems, which were satisfactorily corrected. Unacceptable - The company s performance was entirely unsatisfactory, and you would not do business with them again under any circumstances. There were serious performance issues with the contractor, for which the contractor s corrective actions were ineffective. Contractors must be rated as Acceptable for Past Performance to be evaluated for Technical Capability and Price. FACTOR (2): Technical Capability Technical capability will be determined solely on the content and merit of the information submitted in response to this request. Therefore, it is incumbent on the interested party to provide sufficient documentation for the Government to make an adequate technical assessment of the contractor's capabilities. Acceptable - The contractor s technical approach meets and /or exceeds the requirements set forth in the SOW. Unacceptable - The contractor s capability does not meet one or more of the specifications set forth in the SOW. Contractors must be rated as Acceptable for Past Performance and Acceptable for Technical Capability to be evaluated for Price. FACTOR (3): Price The Price Quote shall include all price elements applicable to the proposed effort. Basis for Award: To be eligible for an award, an Offeror s quote must be determined acceptable past performance and technical capability. The Government shall evaluate quotes and an award will be made to the responsible Offeror whose acceptable offer meets all past performance, technical capability, and price related factors. Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://sam.gov/. FAR 52.212-4, Contract Terms and Conditions Commercial Products and Commercial Services NOV 2023. The full text of FAR provisions or clauses may be accessed electronically at https://www.acquisition.gov/browse/index/far. https://www.va.gov/oal/library/vaar/ 52.222-90 Addressing DEI Discrimination by Federal Contractors. As prescribed in 22.2203, insert the following clause: Addressing DEI Discrimination by Federal Contractors (Deviation DATE) (a) Definitions. As used in this clause Program participation means membership or participation in, or access or admission to: training, mentoring, or leadership development programs; educational opportunities; clubs; associations; or similar opportunities that are sponsored or established by the contractor or subcontractor. Racially discriminatory diversity, equity, and inclusion (DEI) activities means disparate treatment based on race or ethnicity in the recruitment, employment (e.g., hiring, promotions), contracting (e.g., vendor agreements), program participation, or allocation or deployment of an entity's resources. (b) In connection with the performance of work under this contract, the Contractor agrees as follows: (1) The Contractor will not engage in any racially discriminatory DEI activities; (2) The Contractor will furnish all information and reports, including providing access to books, records, and accounts, as required by the Contracting Officer, for purposes of ascertaining compliance with this clause; (3) In the event of the Contractor's or a subcontractor's noncompliance with this clause, this contract may be canceled, terminated, or suspended in whole or in part, and the Contractor or subcontractor may be declared ineligible for further Government contracts; (4) The Contractor will report any subcontractor's known or reasonably knowable conduct that may violate this clause to the Contracting Officer and take any appropriate remedial actions directed by the Contracting Officer; and (5) The Contractor will inform the Contracting Officer if a subcontractor sues the Contractor and the suit puts at issue, in any way, the validity of this clause. (6) The Contractor recognizes that compliance with the requirements of this clause are material to the Government's payment decisions for purposes of 31 U.S.C. 3729(b)(4). (c) The Contractor must include the substance of this clause, including this paragraph (c), in subcontracts at any tier, including those for commercial products and commercial services, except those where the place of delivery or performance is outside the United States. (End of clause) Contract Clauses (Incorporated by Reference) Clause Title Date FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements Jan 2025 FAR 52.204-13 System for Award Management Maintenance Oct 2018 FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment Jan 2025 52.203-17 Contractor Employee Whistleblower Rights and Requirement To Inform Employees of Whistleblower Rights Jun 2020 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards Jun 2020 52.204-27 Prohibition on a ByteDance Covered Application Jun 2023 52.219-28 Post-Award Small Business Program Representation Feb 2024 52.222-3 Convict Labor Jun 2003 52.222-19 Child Labor-Cooperation with Authorities and Remedies Feb 2024 52.222-21 Prohibition of Segregated Facilities Apr 2015 52.222-26 Equal Opportunity Sep 2016 52.222-36 Equal Opportunity for Workers with Disabilities Jun 2020 52.222-50 Combating Trafficking in Persons Nov 2021 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving Jun 2020 52.225-1 Buy American -Supplies Oct 2022 52.225-13 Restrictions on Certain Foreign Purchases Feb 2021 52.232-33 Payment by Electronic Funds Transfer-System for Award Management Oct 2018 To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" Quoters shall list exception(s) and rationale for the exception(s), if any. Submission of your response shall be received not later than 11/27/2026 at 12pm ET. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below. Point of Contact Alison Klein at [email protected]

Contacts

Attachments

BidLookup records the links this notice gives. It has not downloaded or checked the files.

Record dates

Posted on SAM.gov: Nov 17, 2026
The agency’s publication date, as SAM.gov states it.
First recorded by BidLookup: Nov 17, 2026
The UTC day of the first read of SAM.gov’s listings that stored this notice.
Last confirmed: Nov 17, 2026
The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.

Published by the agency on SAM.gov as notice b0b1581a6a1441b9a46d407375bc44d0. What these dates mean

Record

Solicitation number
36C24527Q0070
Search the index for this number
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product/service code
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Place of performance
Baltimore, Maryland 21201
Contracting office
LINTHICUM, MD 21090
SAM.gov notice ID
b0b1581a6a1441b9a46d407375bc44d0